| Danny Earl Montgolf, CRNA | |
|
301 E 18th St, Anniston, AL 36207-3952 | |
| (256) 235-8900 | |
| (256) 236-2503 |
| Full Name | Danny Earl Montgolf |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 41 Years |
| Location | 301 E 18th St, Anniston, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013982123 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1-076533 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Alabama Regional Medical Center | Anniston, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates | 3476570870 | 81 |
News Archive
Artificial intelligence, machine learning, blockchain, and other key digital technology applications will play a vital role addressing the new healthcare challenges triggered by the COVID-19 pandemic, according to a peer-reviewed Special Issue of OMICS: A Journal of Integrative Biology.
Researchers speaking at the American Association for the Advancement of Science (AAAS) meeting on Saturday, discussed how a strategy to promote universal voluntary HIV tests and early antiretroviral treatment for patients living in high-risk areas might "derail the spread of [HIV/]AIDS, a battle where a successful vaccine remains elusive," the Associated Press/Washington Post reports
In this study, a team of researchers from Japanese institutions provide a panel of broadly neutralizing nanobodies that detect four VOCs.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it is entering the final phase of its commercialization program for its first cell culturing devices for the StemDisc family of stem cell culturing products.
› Verified 5 days ago
| Entity Name | Anesthesia Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821013905 PECOS PAC ID: 3476570870 Enrollment ID: O20051025000816 |
News Archive
Artificial intelligence, machine learning, blockchain, and other key digital technology applications will play a vital role addressing the new healthcare challenges triggered by the COVID-19 pandemic, according to a peer-reviewed Special Issue of OMICS: A Journal of Integrative Biology.
Researchers speaking at the American Association for the Advancement of Science (AAAS) meeting on Saturday, discussed how a strategy to promote universal voluntary HIV tests and early antiretroviral treatment for patients living in high-risk areas might "derail the spread of [HIV/]AIDS, a battle where a successful vaccine remains elusive," the Associated Press/Washington Post reports
In this study, a team of researchers from Japanese institutions provide a panel of broadly neutralizing nanobodies that detect four VOCs.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it is entering the final phase of its commercialization program for its first cell culturing devices for the StemDisc family of stem cell culturing products.
› Verified 5 days ago
| Entity Name | Epix Anesthesia Of Alabama Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629427059 PECOS PAC ID: 8022300748 Enrollment ID: O20160715001459 |
News Archive
Artificial intelligence, machine learning, blockchain, and other key digital technology applications will play a vital role addressing the new healthcare challenges triggered by the COVID-19 pandemic, according to a peer-reviewed Special Issue of OMICS: A Journal of Integrative Biology.
Researchers speaking at the American Association for the Advancement of Science (AAAS) meeting on Saturday, discussed how a strategy to promote universal voluntary HIV tests and early antiretroviral treatment for patients living in high-risk areas might "derail the spread of [HIV/]AIDS, a battle where a successful vaccine remains elusive," the Associated Press/Washington Post reports
In this study, a team of researchers from Japanese institutions provide a panel of broadly neutralizing nanobodies that detect four VOCs.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it is entering the final phase of its commercialization program for its first cell culturing devices for the StemDisc family of stem cell culturing products.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danny Earl Montgolf, CRNA Po Box 38, Anniston, AL 36202-0038 Ph: (256) 235-8900 | Danny Earl Montgolf, CRNA 301 E 18th St, Anniston, AL 36207-3952 Ph: (256) 235-8900 |
News Archive
Artificial intelligence, machine learning, blockchain, and other key digital technology applications will play a vital role addressing the new healthcare challenges triggered by the COVID-19 pandemic, according to a peer-reviewed Special Issue of OMICS: A Journal of Integrative Biology.
Researchers speaking at the American Association for the Advancement of Science (AAAS) meeting on Saturday, discussed how a strategy to promote universal voluntary HIV tests and early antiretroviral treatment for patients living in high-risk areas might "derail the spread of [HIV/]AIDS, a battle where a successful vaccine remains elusive," the Associated Press/Washington Post reports
In this study, a team of researchers from Japanese institutions provide a panel of broadly neutralizing nanobodies that detect four VOCs.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it is entering the final phase of its commercialization program for its first cell culturing devices for the StemDisc family of stem cell culturing products.
› Verified 5 days ago
Mrs. Alicia Lindley Webb, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5121 | |
Sally L Haynes, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5860 | |
Florence J Harvey, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 301 E 18th St, Anniston, AL 36207 Phone: 256-235-8751 | |
Neal D Mulkey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5860 | |
Lew A Prince, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5860 | |
Jeffrey Ramsey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 400 E 10th St, Anniston, AL 36207 Phone: 256-235-5121 |